2002
DOI: 10.3892/or.9.6.1373
|View full text |Cite
|
Sign up to set email alerts
|

Gene copy numbers of erbB oncogenes in human pheochromocytoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
5
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 0 publications
2
5
0
Order By: Relevance
“…found that high ERBB2 immunostaining positivity in phaeochromocytoma showed a malignant behaviour. This phenomenon was also observed by our study and several other studies . However, de Krijger et al .…”
Section: Discussionsupporting
confidence: 93%
“…found that high ERBB2 immunostaining positivity in phaeochromocytoma showed a malignant behaviour. This phenomenon was also observed by our study and several other studies . However, de Krijger et al .…”
Section: Discussionsupporting
confidence: 93%
“…The studies on receptors in ErbB family showed a connection between their detectable expression and the incidence of malignant or family PHEO types. However, the results of this research is still ambiguous [24,25] .…”
Section: Introductionmentioning
confidence: 98%
“…We did not find any relationship between these amplifications and other clinical parameters. The deletions of the ErbB-2/Her-2 gene found in two cases are not common in any type of tumours where mainly amplifications play an important role in carcinogenesis and are a prognostic factor (Sworczak et al, 2002;Xu et al, 2002;Awaya et al, 2005;Freundenberg et al, 2005).…”
Section: Discussionmentioning
confidence: 96%
“…ErbB/ Her genes are often mutated or have altered expression in cancer and precancerous cells, which is often a sign of progression and development of disease (Vogt et al, 1998;Xu et al, 2002;Awaya et al, 2005;Saxby et al, 2005;Sassen et al, 2008). ErbB/Her aberrations have also been reported in some types of endocrine lesions, e.g., of thyroid, pheochromocytoma and pancreas (Sworczak et al, 2002;Freudenberg et al, 2005;Saxby et al, 2005;Lee et al, 2007). ErbB-1/Her-1/EGFR expression has been found in pHPT-related adenomas and hyperplasia (Sadler et al, 1996;Gülkesen et al, 2001) and, interestingly, recent data have documented an involvement of its activation in the initiation of parathyroid hyperplasia as a consequence of secondary hyperparathyroidism (Cozzolino et al, 2005).…”
Section: Sporadicmentioning
confidence: 99%